AlphaFold predicted structure
AGPS · O00116

Mean pLDDT
88.4/ 100
Confident
658 residues
Confidence breakdown
- Very high(≥ 90)81%
- Confident(70–90)4%
- Low(50–70)3%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
alkylglycerone phosphate synthase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalChondrodysplasia punctata
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPeroxisomal disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+6 more panels — install the extension to see the full list inline on any page.
rhizomelic chondrodysplasia punctata type 3
rhizomelic chondrodysplasia punctata
neurodegenerative disease
alkylglycerone-phosphate synthase deficiency
Abnormality of the skeletal system
cervical carcinoma
placenta praevia
insomnia
hereditary disease
synpolydactyly
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Alkyldihydroxyacetonephosphate synthase, peroxisomal
Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis
AGPS · O00116

Mean pLDDT
88.4/ 100
Confident
658 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0